Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion ; volume:5 ; number:3 ; year:2020
Biomedicine hub ; 5, Heft 3 (2020)
- Urheber
-
Horgan, Denis
Metspalu, Andres
Ouillade, Marie-Christine
Athanasiou, Dimitrios
Pasi, John
Adjali, Oumeya
Harrison, Patrick
Hermans, Cedric
Codacci-Pisanelli, Giovanni
Koeva, Jasmina
Szucs, Thomas
Cursaru, Viorica
Belina, Ivica
Bernini, Chiara
Zhuang, Suijie
McMahon, Stephen
Toncheva, Draga
Thum, Thomas
- DOI
-
10.1159/000511678
- URN
-
urn:nbn:de:101:1-2020123023142855641497
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Horgan, Denis
- Metspalu, Andres
- Ouillade, Marie-Christine
- Athanasiou, Dimitrios
- Pasi, John
- Adjali, Oumeya
- Harrison, Patrick
- Hermans, Cedric
- Codacci-Pisanelli, Giovanni
- Koeva, Jasmina
- Szucs, Thomas
- Cursaru, Viorica
- Belina, Ivica
- Bernini, Chiara
- Zhuang, Suijie
- McMahon, Stephen
- Toncheva, Draga
- Thum, Thomas
Ähnliche Objekte (12)
Innovation and competition in advanced therapy medicinal products
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
Advanced Therapy Medicinal Products: Availability, Access and Expenditure in Italy
Advanced Therapy Medicinal Products and the Changing Role of Academia
Development and Non-invasive Quality Assessment of Advanced Therapy Medicinal Products
The economics of manufacturing clinical-grade advanced therapy medicinal products (ATMPs)
Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
Natural products in medicinal chemistry
Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
Challenges for Plasma-Derived Medicinal Products
Challenges for Plasma-Derived Medicinal Products
Advanced healthcare materials
Innovation and competition in advanced therapy medicinal products
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
Advanced Therapy Medicinal Products: Availability, Access and Expenditure in Italy
Advanced Therapy Medicinal Products and the Changing Role of Academia
Development and Non-invasive Quality Assessment of Advanced Therapy Medicinal Products
The economics of manufacturing clinical-grade advanced therapy medicinal products (ATMPs)
Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
Natural products in medicinal chemistry
Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
Challenges for Plasma-Derived Medicinal Products
Challenges for Plasma-Derived Medicinal Products
Advanced healthcare materials
Innovation and competition in advanced therapy medicinal products
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
Advanced Therapy Medicinal Products: Availability, Access and Expenditure in Italy
Advanced Therapy Medicinal Products and the Changing Role of Academia
Development and Non-invasive Quality Assessment of Advanced Therapy Medicinal Products
The economics of manufacturing clinical-grade advanced therapy medicinal products (ATMPs)
Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
Natural products in medicinal chemistry
Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
Challenges for Plasma-Derived Medicinal Products
Challenges for Plasma-Derived Medicinal Products